emerging synthetic and natural psychoactive drugs in miami ...€¦ · natural psychedelic drugs....
TRANSCRIPT
BIVARIATE LOGISTIC REGRESSION MODELS TO PREDICT
NATURAL PSYCHEDELIC USE (N=57)
BIVARIATE LOGISTIC REGRESSION MODELS TO PREDICT
SYNTHETIC STIMULANT / PSYCHEDELIC USE (N=34)
DEMOGRAPHICS p OR 95% CI DEMOGRAPHICS p OR 95% Cl
Age under 24 <.001 3.79 1.97, 7.32 Age under 24 ns 0.88 0.43, 1.82
Hispanic .003 2.85 1.44, 5.64 Hispanic ns 0.96 0.46, 2.01
African American .010 0.24 0.08, 0.71 African American ns 0.67 0.24, 1.82
Severe mental distress .015 2.13 1.16, 3.93 Severe mental distress .021 2.47 1.14, 5.32
DSM substance dependence
dedependence
.032 1.99 1.06, 3.73 DSM substance dependence ns 2.08 0.95, 4.56
Injected drugs past 90 days ns 2.00 0.96, 4.17 Injected drugs past 90 days .009 2.97 1.31, 6.73
Drug-related psych problems ns 1.45 0.76, 2.74 Drug-related psych problems .008 3.81 1.42,10.23
Drug-related physical problems ns 1.77 0.96, 3.28 Drug-related physical problems .003 3.82 1.59, 9.16
BIVARIATE LOGISTIC REGRESSION MODELS TO PREDICT
SYNTHETIC CANNABINOID USE (N=33)
DEMOGRAPHICS p OR 95% CI
Age under 24 .017 2.63 1.19, 5.79
Hispanic .047 2.34 1.01, 5.44
African American ns 0.37 0.11, 1.26
Severe mental distress ns 1.13 0.54, 2.35
DSM substance dependence ns 1.25 0.59, 2.64
Injected drugs past 90 days ns 1.78 0.74, 4.29
Drug-related psych problems ns 1.60 0.71, 3.62
Drug-related physical problems ns 2.13 0.97, 4.70
Emerging Synthetic and Natural Psychoactive
Drugs in Miami’s Club Scene:
Users’ Demographic and Health Risk Profiles
Dr. Steven P. Kurtz ARSH, Nova Southeastern University: arsh.nova.edu
[email protected] 2 NE 40th Street, Suite 404, Miami, FL 33137
A randomized clinical trial of
behavioral interventions to reduce
drug use and HIV risk among
young adults in the club scene.
Aim: Ecstasy use has stabilized in the past decade,
but other classes of drugs are increasingly prevalent in
recreational drug use settings. These include synthetic
stimulants, psychedelics, and cannabinoids, as well as
natural psychedelic drugs. There is little information
about the demographic and health risk profiles of users
of these emerging drugs in the United States.
Methods: Eligible respondents (N=243) were ages 18
to 39 and reported recent use of club drugs and misuse
of prescription opioids and/or benzodiazepines.
Interviewers administered standardized health and
social risk assessments. Drugs of interest were
categorized for analysis: 1) natural psychedelics (e.g.,
psilocybin mushrooms, salvia), 2) synthetic
cannabinoids; and 3) synthetic psychedelics and
stimulants (e.g., 2C-x, mephedrone, BZP). Logistic
regression models examined demographic and health
risk characteristics of users of each category.
Age (median) 26 years
Male gender 64.6%
Ethnicity
Hispanic 59.6%
African American 19.8%
White/Other 20.6%
Education
Less than HS 16.5%
High School 35.4%
More than HS 48.1%
Severe mental distress 48.6%
DSM IV substance dependence 56.0%
Sample Characteristics (N=243)
Aims and Methods
Contact This research was supported by Grant Number R01DA019048 from the National Institute on Drug Abuse.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.
.
Results
Financial Support
The South Beach Project 2
Miami is an international center of nightclub culture,
where alcohol, illicit drugs, and prescription drugs are
often sequenced and/or combined. The tendency to mix
numerous substances puts nightclub attendees at high
risk for health and social consequences of drug abuse.
95.1% 94.1%
45.7%
26.7%
22.2% 21.0% 23.5%
14.0% 13.6%
93.0%
85.6%
45.3%
16.5%
Alcohol and marijuana not shown,
as both approach 100%
Discussion
Overlap of use of the three emerging categories of drugs was less
than 30%, except for synthetic and natural psychedelics where the
overlap was 44%.
Younger and Hispanic participants were more likely than others to be
recent users of both natural psychedelics and synthetic cannabinoids.
Demographics were unrelated to the use of synthetic
stimulants/psychedelics.
Recent users of synthetic stimulants and psychedelics appear to be at
high risk for drug injection and drug-related health problems. Natural
psychedelic users were also more likely to report severe mental
distress and substance dependence. None of these health risks
were associated with synthetic cannabinoid use.
Targeted information campaigns and prevention interventions are
warranted.
Steven P. Kurtz
Mance E. Buttram
Hilary L. Surratt
Catherine O’Grady
Shenika Moraldo
Background
Past 90 Day Drug Use / Rx Misuse